Diffuse Alveolar Hemorrhage Associated with Makyo-kanseki-to Administration
Authors:
Open Access
- 1 January 2016
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 55 (22) , 3321-3323
Abstract
We herein describe the first known case of diffuse alveolar hemorrhage (DAH) associated with the administration of Makyo-kanseki-to, a Chinese herbal drug. A 64-year-old man with bronchial asthma presented with persistent cough. Makyo-kanseki-to was prescribed as an adjunctive treatment for bronchial asthma. Immediately after drug ingestion, the patient expectorated bloody sputum. DAH was diagnosed based on the presence of bilateral ground-glass opacity which was identified on chest computed tomography and bloody bronchoalveolar lavage fluid. We diagnosed that the administration of Makyo-kanseki-to was the responsible medication because the hemorrhage developed immediately after drug ingestion and resolved after the cessation of such medication with no subsequent recurrence.Keywords
This publication has 7 references indexed in Scilit:
- Consensus statement for the diagnosis and treatment of drug-induced lung injuriesRespiratory Investigation, 2013
- Diffuse Alveolar HemorrhageChest, 2010
- Interstitial Lung Disease Induced by Drugs and RadiationRespiration, 2004
- Drug-induced diffuse alveolar hemorrhage syndromes and vasculitisClinics in Chest Medicine, 2004
- THE EFFECTS OF MA-XING-GAN-SHI-TANG ON RESPIRATORY RESISTANCE AND AIRWAY LEUKOCYTE INFILTRATION IN ASTHMATIC GUINEA PIGSImmunopharmacology and Immunotoxicology, 2001
- Pneumonitis Induced by Ou-gon (Scullcap).Internal Medicine, 2001
- Alveolar Hemorrhage. Diagnostic Criteria and Results in 194 Immunocompromised HostsAmerican Journal of Respiratory and Critical Care Medicine, 1995